These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 17201611)

  • 21. Pharmacological management of acute agitation.
    Battaglia J
    Drugs; 2005; 65(9):1207-22. PubMed ID: 15916448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intramuscular haloperidol versus intramuscular olanzapine for treatment of acute agitation: a cost-minimization study.
    Freeman DJ; DiPaula BA; Love RC
    Pharmacotherapy; 2009 Aug; 29(8):930-6. PubMed ID: 19637946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial.
    Daniel DG; Potkin SG; Reeves KR; Swift RH; Harrigan EP
    Psychopharmacology (Berl); 2001 May; 155(2):128-34. PubMed ID: 11401000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of short-acting intramuscular antipsychotic medication: impact on length of stay and cost.
    Leung JG; Benedetti AM; Frazee LA; Myers N
    Am J Ther; 2011 Jul; 18(4):300-4. PubMed ID: 20335789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder.
    Simpson GM; Glick ID; Weiden PJ; Romano SJ; Siu CO
    Am J Psychiatry; 2004 Oct; 161(10):1837-47. PubMed ID: 15465981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia.
    Ou JJ; Xu Y; Chen HH; Fan X; Gao K; Wang J; Guo XF; Wu RR; Zhao JP
    Psychopharmacology (Berl); 2013 Feb; 225(3):627-35. PubMed ID: 22926006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Parenteral Antipsychotics in the Treatment of Agitation and Aggression].
    Utzerath G; Reske D; Gouzoulis-Mayfrank E
    Fortschr Neurol Psychiatr; 2015 Dec; 83(12):665-75. PubMed ID: 26714248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Injectable atypical antipsychotics for agitation in borderline personality disorder.
    Pascual JC; Madre M; Soler J; Barrachina J; Campins MJ; Alvarez E; Pérez V
    Pharmacopsychiatry; 2006 May; 39(3):117-8. PubMed ID: 16721704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. Ziprasidone I.M. Study Group.
    Brook S; Lucey JV; Gunn KP
    J Clin Psychiatry; 2000 Dec; 61(12):933-41. PubMed ID: 11206599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intramuscular ziprasidone versus haloperidol for managing agitation in Chinese patients with schizophrenia.
    Zhang H; Wang G; Zhao J; Xie S; Xu X; Shi J; Deng H; Li K; Gao C; Wang X; Vanderburg D; Pan S; Tang H; Shu L; Karayal ON
    J Clin Psychopharmacol; 2013 Apr; 33(2):178-85. PubMed ID: 23422376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The tolerability of intramuscular ziprasidone and haloperidol treatment and the transition to oral therapy.
    Daniel DG; Zimbroff DL; Swift RH; Harrigan EP
    Int Clin Psychopharmacol; 2004 Jan; 19(1):9-15. PubMed ID: 15101564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?
    Oechsner M; Korchounov A
    Hum Psychopharmacol; 2005 Apr; 20(3):203-5. PubMed ID: 15799011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia.
    Wright P; Birkett M; David SR; Meehan K; Ferchland I; Alaka KJ; Saunders JC; Krueger J; Bradley P; San L; Bernardo M; Reinstein M; Breier A
    Am J Psychiatry; 2001 Jul; 158(7):1149-51. PubMed ID: 11431240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case reports of postmarketing adverse event experiences with olanzapine intramuscular treatment in patients with agitation.
    Marder SR; Sorsaburu S; Dunayevich E; Karagianis JL; Dawe IC; Falk DM; Dellva MA; Carlson JL; Cavazzoni PA; Baker RW
    J Clin Psychiatry; 2010 Apr; 71(4):433-41. PubMed ID: 20156413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intramuscular ziprasidone: moving beyond the conventional in the treatment of acute agitation in schizophrenia.
    Brook S
    J Clin Psychiatry; 2003; 64 Suppl 19():13-8. PubMed ID: 14728085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A retrospective study of the safety of intramuscular ziprasidone in agitated elderly patients.
    Greco KE; Tune LE; Brown FW; Van Horn WA
    J Clin Psychiatry; 2005 Jul; 66(7):928-9. PubMed ID: 16013910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia.
    Meehan KM; Wang H; David SR; Nisivoccia JR; Jones B; Beasley CM; Feldman PD; Mintzer JE; Beckett LM; Breier A
    Neuropsychopharmacology; 2002 Apr; 26(4):494-504. PubMed ID: 11927174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of intramuscular olanzapine, orally disintegrating olanzapine tablets, oral risperidone solution, and intramuscular haloperidol in the management of acute agitation in an acute care psychiatric ward in Taiwan.
    Hsu WY; Huang SS; Lee BS; Chiu NY
    J Clin Psychopharmacol; 2010 Jun; 30(3):230-4. PubMed ID: 20473056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Olanzapine versus ziprasidone: results of a 28-week double-blind study in patients with schizophrenia.
    Breier A; Berg PH; Thakore JH; Naber D; Gattaz WF; Cavazzoni P; Walker DJ; Roychowdhury SM; Kane JM
    Am J Psychiatry; 2005 Oct; 162(10):1879-87. PubMed ID: 16199834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of acute undifferentiated agitation in the emergency department: a randomized double-blind trial of droperidol, ziprasidone, and midazolam.
    Martel M; Sterzinger A; Miner J; Clinton J; Biros M
    Acad Emerg Med; 2005 Dec; 12(12):1167-72. PubMed ID: 16282517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.